A startup company, Heliospect Genomics, is offering to help wealthy couples screen their embryos for IQ using controversial technology that raises questions about the ethics of genetic enhancement. Science correspondent Hannah Devlin tells Madeleine Finlay about the joint investigation into the company by the Guardian and the campaign group Hope Not Hate
US startup charging couples to ‘screen embryos for IQ’
More Stories
Exercise ‘better than drugs’ to stop cancer returning after treatment, trial finds
Elon Musk shows he still has the White House’s ear on Trump’s Middle East trip
New AI test can predict which men will benefit from prostate cancer drug